Lab
Laboratory Corporation of America
Laboratory Corporation of America was paid $13.05M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 88175, Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer — 34% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA
MONROVIA, CA 91016
MONROVIA, CA 91016
33aNPI1730459025assigned 01/04/2012
33bProvider typeClinical Medical Laboratory
28Total paid$13.05M
24GClaims587,747
24DCodes billed93
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#58 of 561
Median peer was paid$222K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 94,416 | $2.25M | |
| 2019 | 77,401 | $1.52M | |
| 2020 | 62,054 | $1.39M | |
| 2021 | 105,398 | $2.37M | |
| 2022 | 87,071 | $1.74M | |
| 2023 | 88,869 | $2.09M | |
| 2024incomplete | 72,538 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 34% | 233,441 | 217,396 | $4.39M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 31% | 158,090 | 147,038 | $4.00M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 22% | 39,085 | 38,171 | $2.93M |
| 88142 | 3.1% | 28,166 | 27,128 | $403K | |
| 88342 | 1.8% | 5,439 | 5,325 | $233K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 23,144 | 22,961 | $195K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.5% | 23,152 | 22,973 | $195K |
| 88141 | 1.5% | 26,295 | 26,139 | $190K | |
| 88307 | 1.1% | 1,279 | 1,279 | $141K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 10,403 | 10,026 | $105K |
| 88341 | <1% | 1,429 | 1,386 | $97K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 319 | 316 | $29K |
81 more codes
| 88304 | <1% | 1,483 | $23K | |
| 87625 | <1% | 894 | $21K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,075 | $18K |
| 88312 | <1% | 1,327 | $17K | |
| 88321 | <1% | 343 | $17K | |
| 88112 | <1% | 616 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,680 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 3,103 | $4K |
| 80061 | Lipid panel | <1% | 2,700 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,197 | $3K |
| 87529 | <1% | 1,148 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,360 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,692 | $3K |
| 88360 | <1% | 13 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 818 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,439 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 65 | $769.65 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 241 | $746.25 |
| 86592 | <1% | 673 | $703.82 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 295 | $578.49 |
| 99199 | Unlisted special service, procedure or report | <1% | 69 | $537.50 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 707 | $497.66 |
| 84439 | <1% | 1,072 | $401.40 | |
| 80074 | <1% | 95 | $274.87 | |
| 86480 | <1% | 106 | $267.14 | |
| 82607 | <1% | 567 | $232.39 | |
| 86803 | <1% | 562 | $227.50 | |
| 82728 | <1% | 265 | $225.15 | |
| 88164 | <1% | 1,714 | $200.87 | |
| 82746 | <1% | 418 | $176.75 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 145 | $155.39 |
| 88344 | <1% | 13 | $147.71 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 457 | $146.22 |
| 83550 | <1% | 258 | $142.75 | |
| 81001 | <1% | 616 | $140.58 | |
| 82274 | <1% | 183 | $128.34 | |
| 83540 | <1% | 270 | $122.25 | |
| 82043 | <1% | 480 | $99.42 | |
| 82570 | <1% | 421 | $90.11 | |
| 87088 | <1% | 210 | $70.98 | |
| 87186 | <1% | 182 | $63.15 | |
| 80081 | <1% | 29 | $51.99 | |
| 83013 | <1% | 22 | $46.78 | |
| 84702 | <1% | 47 | $31.38 | |
| 81003 | <1% | 134 | $31.14 | |
| 86696 | <1% | 60 | $26.88 | |
| 84153 | <1% | 139 | $25.56 | |
| 86695 | <1% | 60 | $18.32 | |
| 85652 | <1% | 118 | $15.80 | |
| 86140 | <1% | 59 | $15.47 | |
| 85027 | <1% | 204 | $14.88 | |
| 87077 | <1% | 56 | $11.80 | |
| 82950 | <1% | 32 | $9.87 | |
| 83655 | <1% | 57 | $9.28 | |
| 87081 | <1% | 14 | $9.20 | |
| 87340 | <1% | 47 | $7.18 | |
| 83735 | <1% | 12 | $4.65 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 278 | $0.00 |
| 84436 | 0% | 16 | $0.00 | |
| 86376 | 0% | 53 | $0.00 | |
| 86160 | 0% | 15 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 32 | $0.00 |
| 86225 | 0% | 17 | $0.00 | |
| 83002 | 0% | 12 | $0.00 | |
| 86038 | 0% | 63 | $0.00 | |
| 84550 | 0% | 57 | $0.00 | |
| 86256 | 0% | 45 | $0.00 | |
| 88147 | 0% | 179 | $0.00 | |
| 86200 | 0% | 15 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 200 | $0.00 |
| 86235 | 0% | 38 | $0.00 | |
| 82785 | 0% | 48 | $0.00 | |
| 86003 | 0% | 110 | $0.00 | |
| 83516 | 0% | 143 | $0.00 | |
| 84450 | 0% | 27 | $0.00 | |
| 84482 | 0% | 12 | $0.00 | |
| 82565 | 0% | 14 | $0.00 | |
| 82977 | 0% | 14 | $0.00 | |
| 86431 | 0% | 30 | $0.00 | |
| 85610 | 0% | 12 | $0.00 | |
| 84520 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VP)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.